Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities


Wyeth is to acquire Haptogen, the Aberdeen-based biopharmaceutical therapies company with 30 staff, for an estimated £25m.

Wyeth Pharmaceuticals is considering plans to relocate its UK headquarters from Maidenhead to a 100,000 sq ft site at Green Park in Reading.

Wyeth Pharmaceuticals is seeking a suitable site to open a 100,000 sq ft office between Reading and Slough.

Wyeth and Scottish Enterprise are to invest £50m in medical research work in Scotland, including drug development at the universities of Glasgow, Aberdeen, Edinburgh and Dundee, and a central research centre with 50 staff in Dundee.